Surface Charge of Streptococcus pneumoniae Predicts Serotype Distribution

ABSTRACT Streptococcus pneumoniae (pneumococcus) frequently colonizes the human nasopharynx and is an important cause of pneumonia, meningitis, sinusitis, and otitis media. The outer cell surface of pneumococcus may assume various degrees of negative charge depending on the polysaccharide capsule, of which more than 90 serotypes have been identified. The negative charge of capsular polysaccharides has been proposed to electrostatically repel pneumococci from phagocytic cells, and avoidance of phagocytosis correlates with higher carriage prevalence. We hypothesized that the surface charge of pneumococcus contributes to its success in nasopharyngeal carriage by modulating resistance to phagocyte-mediated killing. Here, we measured the surface charge (zeta potential) of laboratory-constructed strains that share a genetic background but differ in serotype and of clinical strains that differ in serotype and genetic background. A more negative surface charge correlated with higher resistance to nonopsonic killing by human neutrophils in vitro. In addition, a more negative zeta potential was associated with higher carriage prevalence in human populations before and after the widespread use of the pneumococcal conjugate vaccine PCV7. We also confirmed that capsule is the major determinant of net surface charge in clinical isolates with diverse backgrounds. We noted that exceptions exist to the idea that a higher magnitude of negative charge predicts higher prevalence. The results indicated that zeta potential is strongly influenced by pneumococcal capsule type but is unlikely to be the only important mechanism by which capsule interacts with host.

[1]  M. Lipsitch,et al.  Streptococcus pneumoniae Capsular Serotype Invasiveness Correlates with the Degree of Factor H Binding and Opsonization with C3b/iC3b , 2012, Infection and Immunity.

[2]  S. Clarke,et al.  Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults , 2012, Expert review of vaccines.

[3]  K. O'Brien,et al.  The fundamental link between pneumococcal carriage and disease , 2012, Expert review of vaccines.

[4]  H. Djalilian,et al.  Detecting Nasopharyngeal Reflux: A Novel pH Probe Technique , 2012, The Annals of otology, rhinology, and laryngology.

[5]  A. D'Amour,et al.  Estimating Rates of Carriage Acquisition and Clearance and Competitive Ability for Pneumococcal Serotypes in Kenya With a Markov Transition Model , 2012, Epidemiology.

[6]  M. Lipsitch,et al.  The Prevalence and Risk Factors for Pneumococcal Colonization of the Nasopharynx among Children in Kilifi District, Kenya , 2012, PloS one.

[7]  M. Lipsitch,et al.  Serotype replacement in disease after pneumococcal vaccination , 2011, The Lancet.

[8]  D. Briles,et al.  Streptococcus pneumoniae Isolates from Middle Ear Fluid and Nasopharynx of Children with Acute Otitis Media Exhibit Phase Variation , 2011, Journal of Clinical Microbiology.

[9]  M. Sperandio,et al.  Myeloperoxidase attracts neutrophils by physical forces. , 2011, Blood.

[10]  C. Fraser,et al.  Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. , 2010, Epidemics.

[11]  Thomas B. Clarke,et al.  Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. , 2009, The Journal of clinical investigation.

[12]  J. Galagan,et al.  Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence , 2009, PLoS pathogens.

[13]  M. Lipsitch,et al.  Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization , 2008, PLoS pathogens.

[14]  W. Schaffner,et al.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. , 2007, The Journal of infectious diseases.

[15]  L. Hammitt,et al.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. , 2007, JAMA.

[16]  M. Lipsitch,et al.  Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. , 2007, The Journal of infectious diseases.

[17]  M. Lipsitch,et al.  Age- and Serogroup-Related Differences in Observed Durations of Nasopharyngeal Carriage of Penicillin-Resistant Pneumococci , 2007, Journal of Clinical Microbiology.

[18]  A. Nelson,et al.  Capsule Enhances Pneumococcal Colonization by Limiting Mucus-Mediated Clearance , 2006, Infection and Immunity.

[19]  T. Peto,et al.  Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. , 2006, The Journal of infectious diseases.

[20]  João André Carriço,et al.  Effect of the Seven-Valent Conjugate Pneumococcal Vaccine on Carriage and Drug Resistance of Streptococcus pneumoniae in Healthy Children Attending Day-Care Centers in Lisbon , 2005, The Pediatric infectious disease journal.

[21]  D. Feikin,et al.  Epidemiological differences among pneumococcal serotypes. , 2005, The Lancet. Infectious diseases.

[22]  K. Auranen,et al.  Invasiveness of Serotypes and Clones of Streptococcus pneumoniae among Children in Finland , 2005, Infection and Immunity.

[23]  Richard Platt,et al.  Post-PCV7 Changes in Colonizing Pneumococcal Serotypes in 16 Massachusetts Communities, 2001 and 2004 , 2004, Pediatrics.

[24]  B. Spratt,et al.  Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. , 2004, The Journal of infectious diseases.

[25]  R. de Groot,et al.  Streptococcus pneumoniae colonisation: the key to pneumococcal disease. , 2004, The Lancet. Infectious diseases.

[26]  M. Lipsitch,et al.  Construction of Otherwise Isogenic Serotype 6B, 7F, 14, and 19F Capsular Variants of Streptococcus pneumoniae Strain TIGR4 , 2003, Applied and Environmental Microbiology.

[27]  Steven Black,et al.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The Journal of pediatrics.

[28]  B. Spratt,et al.  Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. , 2003, The Journal of infectious diseases.

[29]  A. Schuchat,et al.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The New England journal of medicine.

[30]  Marc Lipsitch,et al.  Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States , 2003, Nature Medicine.

[31]  H. Pfister,et al.  Pathogenesis and pathophysiology of pneumococcal meningitis. , 2002, The Lancet. Infectious diseases.

[32]  E. Swiatlo,et al.  Contribution of Choline-Binding Proteins to Cell Surface Properties of Streptococcus pneumoniae , 2002, Infection and Immunity.

[33]  F. Babl,et al.  Constancy of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  F. Champlin,et al.  Status of methods for assessing bacterial cell surface charge properties based on zeta potential measurements. , 2001, Journal of microbiological methods.

[35]  L. Harrison,et al.  Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.

[36]  G. Siber,et al.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  H. Masure,et al.  Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization , 1994, Infection and immunity.

[38]  R. Austrian.  Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. , 1981, Reviews of infectious diseases.

[39]  T. Kozel,et al.  Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide. , 1980, Infection and immunity.

[40]  C. J. Oss,et al.  Phagocytosis as a Surface Phenomenon , 1978 .

[41]  C. V. van Oss.  Phagocytosis as a surface phenomenon. , 1978, Annual review of microbiology.

[42]  A. W. Bernheimer.  SYNTHESIS OF TYPE III PNEUMOCOCCAL POLYSACCHARIDE BY SUSPENSIONS OF RESTING CELLS , 1953, The Journal of experimental medicine.

[43]  M. H. Adams,et al.  A Partially Defined Medium for Cultivation of Pneumococcus , 1945, Journal of bacteriology.